Sodium Hydroxide → 1-[4-chloro-6-(methylamino)-1,3,5-triazin-2-yl]-N-{[-(trifluoromethyl)phenyl]methyl}-4-piperidinecarboxamide
반응식
[F:1][C:2]([F:20])([F:19])[C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[CH2:9][NH:10][C:11]([CH:13]1[CH2:18][CH2:17][NH:16][CH2:15][CH2:14]1)=[O:12].[Cl:21][C:22]1[N:27]=[C:26](Cl)[N:25]=[C:24]([NH:29][CH3:30])[N:23]=1.[OH-].[Na+]>>[Cl:21][C:22]1[N:23]=[C:24]([NH:29][CH3:30])[N:25]=[C:26]([N:16]2[CH2:17][CH2:18][CH:13]([C:11]([NH:10][CH2:9][C:4]3[CH:5]=[CH:6][CH:7]=[CH:8][C:3]=3[C:2]([F:1])([F:19])[F:20])=[O:12])[CH2:14][CH2:15]2)[N:27]=1참가 물질
4
반응 조건
- 온도
- 40 °C
실험 절차
N-{[2-(Trifluoromethyl)phenyl]methyl}-4-piperidinecarboxamide (464 mg, 1.63 mmol, 1.00 equiv) was added to the suspension prepared in step b. The resulting mixture was heated to 40° C. and treated with 1 N NaOH to maintain a pH of 9-10. The reaction mixture was stirred for 2 h and then used immediately in the next step without workup or purification. MS (ES+): m/e 428.9 [M+H]+.
후처리
- temperatureto maintain a pH of 9-10
- customused immediately in the next step without workup or purification
출처 및 근거
- ORD 기록
- ord-35ca18e7b8e34ebdb2631e01f38b11be
- 출처 데이터셋
- uspto-grants-2011_08
- 특허 번호
- US08008483B2
반응 노트
불러오는 중…